Broadcom's AI Revenue Just Soared 221%, and Profits Tripled. So, Why Is the Stock Flat?
Source: The Motley Fool
Broadcom (AVGO) reported fiscal Q3 revenue of $29.6B (+86% YoY, beating the $29.4B consensus) and adjusted EPS of $3.32 (+96% YoY vs $3.24 expected). It guided Q4 revenue to $34.8B (+93% YoY vs ~$35.0B expected) and expects AI semiconductor revenue to surge 236% to $21.7B, alongside AI semiconductor revenue up 221% YoY to $16.7B. Despite strong results (FCF $13.7B, +95%), shares were described as flat/soft due to premium valuation and investors reacting with a “shrug” to a forecast that slightly missed.
Analysis
The important signal is not the headline beat; it is that AI spend is still expanding fast enough to support a second wave of beneficiaries beyond the obvious GPU leader. AVGO’s mix implies the next leg of AI monetization is increasingly about infrastructure efficiency, custom silicon, and networking bandwidth, which should keep pressure on optical interconnect, advanced packaging, and HBM suppliers even if hyperscalers try to optimize unit economics.
The muted price response suggests the market is already crowded in the obvious AI winners, so the near-term issue is multiple digestion rather than demand fatigue. That creates a cleaner relative-value setup than an outright directional one: if AI capex stays firm, the group should rerate higher on forward estimates over the next 1-3 months, but if any hyperscaler commentary softens, high-duration semis will de-rate quickly. Falsifiers are simple: a step-down in AI growth rate, margin compression, or a guide that implies spending is being deferred rather than reallocated.
Contrarian takeaway: consensus is treating the small guidance delta as meaningful, but the larger message is that the market may be underpricing how sticky custom AI workloads become once a platform is embedded. That favors AVGO over more sentiment-driven AI names and may also be modestly negative for NVDA at the margin if custom accelerators keep taking inference share, though not enough to break the broader AI cycle. The opportunity is to buy quality on weakness, not chase a breakout after a crowded post-earnings reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
Key Decisions for Investors
- Buy AVGO on a 3-5% post-earnings pullback or on a close back above the 20-day moving average; target a 10-15% rebound over 1-3 months as estimate revisions catch up, with a stop if AI revenue growth meaningfully decelerates next quarter.
- Relative-value: long AVGO / short a semiconductor basket proxy (SOXX or SMH) for 1-3 months to express that custom AI/networking monetization should outperform the broader chip complex if AI capex remains intact.
- Avoid chasing NVDA here; use AVGO strength as confirmation of the AI spending cycle, but keep NVDA as a monitor rather than a fresh long until the market proves it can re-rate both names simultaneously.
- Set an alert for next hyperscaler capex commentary and for any AVGO guide below consensus by >2%; that would be the first credible sign the AI spend curve is flattening and would invalidate the long thesis.
More News
- Tech Rallies on Meta Muse & Alibaba’s China AI Chip
- Alibaba shares jump as new AI chip, data center buildout plans unveiled
- Alibaba Cloud plans six-year stroll to 20GW of datacenters, reveals chip to power them
- Rocket Lab Sold $1.9 Billion of New Stock to Pay for Iridium. Here's the Dilution Math.
- AMD joins the $1 trillion club as chip rally surges - our AI Strategy saw it early
- Intel surges 12% as CPU stocks rally. Here's what's driving the move
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: New Reporting Features, UI Improvements, and Chat Optimizations
- Selecting an AI Research Platform for Institutional Investors